RHBDD1 and lung cancer: Using the Kaplan-Meier plotter online software based on a public database, we determined that the overall survival of lung cancer patients with low expression of RHBDD1 iss better than that for patients with high expression (Fig. 1b; HR = 1.22, 95% CI = 1.03–1.43, p < 0.01).